MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$80,728K
Net unrealized gain
on marketable...
$838K
Net loss
-$81,566K
Interest and other
income, net
$11,319K
Loss from operations
-$90,236K
Loss on
extinguishment of loan payable
-$1,557K
Interest expense
$1,092K
Total operating
expenses
$90,236K
Research and development
$78,883K
General and
administrative
$11,353K
Back
Back
Income Statement
source: myfinsight.com
Akero Therapeutics, Inc. (AKRO)
Akero Therapeutics, Inc. (AKRO)